Literature DB >> 8984217

Acute Chagas' disease: plasma levels of alpha-2-macroglobulin and C-reactive protein in children under 13 years in a high endemic area of Bolivia.

N M Medrano1, M R Luz, P H Cabello, G T Tapia, F Van Leuven, T C Araújo-Jorge.   

Abstract

We measured the levels of two human acute phase proteins (APP), alpha-2-macroglobulin (A2M) and C-reactive protein (CRP), in sera of 56 healthy and 84 acute chagasic children aged from 1 to 13 years old, from a highly endemic area in Bolivia. In such areas, children are continuously exposed to vectors and the frequency of acute cases increases with age. Quantitation of A2M and CRP were performed using sandwich ELISAs, that were shown to be sensitive, reproducible and suited for studying many samples rapidly. A2M levels observed were higher in healthy younger children, decreasing with age until children reached their teens, and their distribution suggested a relationship between A2M concentration and age that could be consistently expressed by a power function. The same does not occur with CRP levels. Concentrations of A2M were age-adjusted to allow comparison using sera collected from children with different ages. Both A2M and CRP were significantly increased in acute chagasic children. Since parasites are commonly present in blood and tissues during the acute phase of Chagas' disease, it is possible that the high levels of A2M may act as inhibitors of a high load of proteinases, derived either from the parasites, from host cell damage or from both.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8984217     DOI: 10.1093/tropej/42.2.68

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  6 in total

1.  Heterogeneity in the synthesis of alpha-macroglobulins in outbred Swiss albino mice acutely infected with Trypanosoma cruzi.

Authors:  M R Luz; F van Leuven; T C de Araújo-Jorge
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

Review 2.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 3.  Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.

Authors:  Ludmila Rodrigues Pinto Ferreira; Amanda Farage Frade; Monique Andrade Baron; Isabela Cunha Navarro; Jorge Kalil; Christophe Chevillard; Edecio Cunha-Neto
Journal:  World J Cardiol       Date:  2014-08-26

4.  Predicting Blood Parasite Load and Influence of Expression of iNOS on the Effect Size of Clinical Laboratory Parameters in Acute Trypanosoma cruzi Infection With Different Inoculum Concentrations in C57BL/6 Mice.

Authors:  Wellington Francisco Rodrigues; Camila Botelho Miguel; Laís Corrêa Marques; Thiago Alvares da Costa; Melissa Carvalho Martins de Abreu; Carlo José Freire Oliveira; Javier Emilio Lazo-Chica
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561

5.  Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19.

Authors:  Olivier Deckmyn; Thierry Poynard; Pierre Bedossa; Valérie Paradis; Valentina Peta; Raluca Pais; Vlad Ratziu; Dominique Thabut; Angelique Brzustowski; Jean-François Gautier; Patrice Cacoub; Dominique Valla
Journal:  Biomedicines       Date:  2022-03-17

6.  Influence of α2-Macroglobulin, Anti-Parasite IgM and ABO Blood Group on Rosetting in Plasmodium falciparum Clinical Isolates and Their Associations with Disease Severity in a Ghanaian Population.

Authors:  Betty Bandoh; Eric Kyei-Baafour; Belinda Aculley; William van der Puije; Bernard Tornyigah; Kwadwo Akyea-Mensah; Lars Hviid; Robert A Ngala; Margaret T Frempong; Michael F Ofori
Journal:  J Blood Med       Date:  2022-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.